Levomefolate is the free-acid form of the active folate coenzyme 5-methyltetrahydrofolate, central to homocysteine remethylation and nucleotide synthesis pathways. Its bioavailability advantage over folic acid in MTHFR-variant populations has driven growing pharmaceutical and nutraceutical interest. Simson Pharma provides a Levomefolate reference standard for assay development across folate-based formulations.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Levomefolate Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.